Current Issue February 2012, Vol. 39, No. 2

Issue Highlights

Review

  • Introduction to the MRSA series of reviews
    February 2012(Vol. 39 | No. 2 | Pages 95)

    Ian Gould

  • New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance
    February 2012(Vol. 39 | No. 2 | Pages 96-104)

    Ian M. Gould, Michael Z. David, Silvano Esposito, Javier Garau, Gerard Lina, Teresita Mazzei, Georg Peters

  • Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
    February 2012(Vol. 39 | No. 2 | Pages 105-114)

    Marie Kempf, Jean-Marc Rolain

  • Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia
    06 February 2012

    Douglas J. Biedenbach, David J. Farrell, Robert K. Flamm, Lisa C. Liverman, Gail McIntyre, Ronald N. Jones

  • Commentary on: Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
    03 February 2012

    Gabriel Levy Hara

  • Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
    27 January 2012

    Gwan-Han Shen, Thomas Chang-Yao Tsao, Shang-Jyh Kao, Jen-Jyh Lee, Yen-Hsu Chen, Wei-Chung Hsieh, Gwo-Jong Hsu, Yen-Tao Hsu, Ching-Tai Huang, Yeu-Jun Lau, Shih-Ming Tsao, Po-Ren Hsueh

  • Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities
    24 January 2012

    Francesco Scaglione, Liberato Berrino

  • Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium
    16 January 2012

    Ann Lismond, Sylviane Carbonnelle, Jan Verhaegen, Patricia Schatt, Annelies De Bel, Paul Jordens, Frédérique Jacobs, Anne Dediste, Frank Verschuren, Te-Din Huang, Paul M. Tulkens, Youri Glupczynski, Françoise Van Bambeke

  • View More Articles in Press...

On the Cover

Cover Image

Journal Access

Full-text articles are available from 1995 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to:

Buy a Subscription Now

Activate Online Access

Publishing Information

International Journal of Antimicrobial Agents is published by Elsevier for the International Society of Chemotherapy (ISC) for Infection and Cancer.

Elsevier

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About International Journal of Antimicrobial Agents

International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, immunotherapeutic agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents, immunomodulators and immunotherapy. Special attention is given to articles providing insight into the problems of antimicrobial resistance, local as well as world-wide, both in the hospital and in the community. Papers on the underlying mechanisms and on immunomodulating agents are also welcome. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.

ISC Information

The general objectives of the International Society of Chemotherapy (ISC) for Infection and Cancer are to advance the education and science of chemotherapy. International congresses and conferences promoting the development of chemotherapy are held regularly. The ISC encourages, supports and sponsors the formation of international working groups for special research projects, commissions, training projects and the use of chemotherapeutics in the field of antimicrobial and antineoplastic chemotherapy. It also helps to co-ordinate the activities of these working groups.